Extent of followup care after elective total hip replacement

Journal of Rheumatology

Volumn 33, Issue 6, 2006, Pages 1159-1166

  De Pablo, Paola ^a   Losina, Elena ^a,b,c   Mahomed, Nizar ^d   Wright, John ^a   Fossel, Anne H ^a   Barrett, Jane A ^e   Katz, Jeffrey N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Followup; Orthopedic; Radiographic; Total hip replacement

Indexed keywords

AGED; ARTICLE; EDUCATION; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HIP RADIOGRAPHY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; QUESTIONNAIRE; TOTAL HIP PROSTHESIS;

AGED; AGED, 80 AND OVER; APPOINTMENTS AND SCHEDULES; ARTHROPLASTY, REPLACEMENT, HIP; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICARE; ORTHOPEDICS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE CARE; RADIOLOGY; SURGICAL PROCEDURES, ELECTIVE;

EID: 33744739843     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Liang MH, Cullen KE, Larson MG, et al. Cost-effectiveness of total joint arthroplasty in osteoarthritis. Arthritis Rheum 1986;29:937-43.
2. Laupacis A, Bourne R, Rorabeck C, et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 1993;75:1619-26.
3. Rissanen P, Aro S, Slatis P, Sintonen H, Paavolainen P. Health and quality of life before and after hip or knee arthroplasty. J Arthroplasty 1995;10:169-75.
4. Harris WH, Sledge CB. Total hip and total knee replacement (1). N Engl J Med 1990;323:725-31.
5. Harris WH, Sledge CB. Total hip and total knee replacement (2). N Engl J Med 1990;323:801-7.
6. National Institutes of Health. National Institutes of Health consensus conference: Total hip replacement. NIH Consensus Development Panel on Total Hip Replacement. JAMA 1995;273:1950-6.
7. Kawamura H, Dunbar MJ, Murray P, Bourne RB, Rorabeck CH. The porous coated anatomic total hip replacement. A ten to fourteen-year follow-up study of a cementless total hip arthroplasty. J Bone Joint Surg Am 2001;83:1333-8.
8. Brown SR, Davies WA, DeHeer DH, Swanson AB. Long-term survival of McKee-Farrar total hip prostheses. Clin Orthop Relat Res 2002:157-63.
9. Hamadouche M, Boutin P, Daussange J, Bolander ME, Sedel L. Alumina-on-alumina total hip arthroplasty: a minimum 18.5-year follow-up study. J Bone Joint Surg Am 2002;84:69-77.
10. Callaghan JJ, Albright JC, Goetz DD, Olejniczak JP, Johnston RC. Charnley total hip arthroplasty with cement. Minimum twenty-five-year follow-up. J Bone Joint Surg Am 2000;82:487-97.
11. Huo MH. What's new in hip arthroplasty. J Bone Joint Surg Am 2002;84:1894-905.
12. Berry DJ, Harmsen WS, Cabanela ME, Morrey BF. Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am 2002;84:171-7.
13. Archibeck MJ, Jacobs JJ, Black J. Alternate bearing surfaces in total joint arthroplasty: biologic considerations. Clin Orthop Relat Res 2000;379:12-21.
14. Berend KR, Lombardi AV Jr, Mallory TH, Adams JB, Russell JH, Groseth KL. The long-term outcome of 755 consecutive constrained acetabular components in total hip arthroplasty examining the successes and failures. J Arthroplasty 2005;20 Suppl 3:93-102.
15. Harris WH. "The lysis threshold": an erroneous and perhaps misleading concept? J Arthroplasty 2003;18:506-10.
16. Orishimo KF, Claus AM, Sychterz CJ, Engh CA. Relationship between polyethylene wear and osteolysis in hips with a second-generation porous-coated cementless cup after seven years of follow-up. J Bone Joint Surg Am 2003;85:1095-9.
17. Berry DJ. Management of osteolysis around total hip arthroplasty. Orthopedics 1999;22:805-8.
18. Lonner JH, Siliski JM, Scott RD. Prodromes of failure in total knee arthroplasty. J Arthroplasty 1999;14:488-92.
19. O'Rourke MR, Callaghan JJ, Goetz DD, Sullivan PM, Johnston RC. Osteolysis associated with a cemented modular posterior-cruciate-substituting total knee design: five to eight-year follow-up. J Bone Joint Surg Am 2002;84:1362-71.
20. Harris WH. Wear and periprosthetic osteolysis: the problem. Clin Orthop 2001;393:66-70.
21. Lavernia CJ. Cost-effectiveness of early surgical intervention in silent osteolysis. J Arthroplasty 1998;13:277-9.
22. Jacobs JJ, Shanbhag A, Glant TT, Black J, Galante JO. Wear debris in total joint replacements. J Am Acad Orthop Surg 1994;2:212-20.
23. Khalily C, Whiteside LA. Predictive value of early radiographic findings in cementless total hip arthroplasty femoral components: an 8- to 12-year follow-up. J Arthroplasty 1998;13:768-73.
24. Iwase T, Wingstrand I, Persson BM, Kesteris U, Hasegawa Y, Wingstrand H. The ScanHip total hip arthroplasty: radiographic assessment of 72 hips after 10 years. Acta Orthop Scand 2002;73:54-9.
25. Lavernia CJ, Drakeford MK, Tsao AK, Gittelsohn A, Krackow KA, Hungerford DS. Revision and primary hip and knee arthroplasty. A cost analysis. Clin Orthop 1995;311:136-41.
26. Barrack RL, Hoffman GJ, Tejeiro WV, Carpenter LJ Jr. Surgeon work input and risk in primary versus revision total joint arthroplasty. J Arthroplasty 1995;10:281-6.
27. Barrack RL, Sawhney J, Hsu J, Cofield RH. Cost analysis of revision total hip arthroplasty. A 5-year followup study. Clin Orthop 1999;369:175-8.
28. Barrack RL. The evolving cost spectrum of revision hip arthroplasty. Orthopedics 1999;22:865-6.
29. Crowe JF, Sculco TP, Kahn B. Revision total hip arthroplasty: hospital cost and reimbursement analysis. Clin Orthop 2003;413:175-82.
30. Kershaw CJ, Atkins RM, Dodd CA, Bulstrode CJ. Revision total hip arthroplasty for aseptic failure. A review of 276 cases. J Bone Joint Surg Br 1991;73:564-8.
31. Roberson JR. Proximal femoral bone loss after total hip arthroplasty. Orthop Clin North Am 1992;23:291-302.
32. Eldridge JD, Smith EJ, Hubble MJ, Whitehouse SL, Learmonth ID. Massive early subsidence following femoral impaction grafting. J Arthroplasty 1997;12:535-40.
33. Meding JB, Ritter MA, Keating EM, Faris PM. Impaction bone-grafting before insertion of a femoral stem with cement in revision total hip arthroplasty. A minimum two-year follow-up study. J Bone Joint Surg Am 1997;79:1834-41.
34. Gie GA, Linder L, Ling RS, Simon JP, Slooff TJ, Timperley AJ. Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg Br 1993;75:14-21.
35. Slooff TJ, Buma P, Schreurs BW, Schimmel JW, Huiskes R, Gardeniers J. Acetabular and femoral reconstruction with impacted graft and cement. Clin Orthop 1996;324:108-15.
36. DeLee JG, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop 1976;121:20-32.
37. Charnley J. Low friction arthroplasty of the hip. Berlin: Springer-Verlag; 1979.
38. Gruen TA, McNeice GM, Amstutz HC. "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop 1979;141:17-27.
39. Schmalzried TP, Kwong LM, Jasty M, et al. The mechanism of loosening of cemented acetabular components in total hip arthroplasty. Analysis of specimens retrieved at autopsy. Clin Orthop 1992;274:60-78.
40. Clohisy JC TS, Ross FP, et al. Blockade of TNF-activation of NF-kB in osteoclast precursors prevents implant osteolysis. J Bone Miner Res 1999;14 Suppl:S489.
41. Schwarz EM, Looney RJ, O'Keefe RJ. Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis. Arthritis Res 2000;2:165-8.
42. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001;16:338-47.
43. Schwarz EM, Campbell D, Totterman S, Boyd A, O'Keefe RJ, Looney RJ. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo. J Orthop Res 2003;21:1049-55.
44. Millett PJ, Allen MJ, Bostrom MP. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 2002;84:236-49.
45. Thadani PJ, Waxman B, Sladek E, Barmada R, Gonzalez MH. Inhibition of paniculate debris-induced osteolysis by alendronate in a rat model. Orthopedics 2002;25:59-63.
46. Nehme A, Maalouf G, Tricoire JL, Giordano G, Chiron P, Puget J. Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study [French]. Rev Chir Orthop Reparatrice Appar Mot 2003;89:593-8.
47. UK National Audit Office. Hip replacements: Getting it right first time. Report by the Comptroller and Auditor General, 19 April 2000. Available from: http://www.nao.org.uk/publications/nao_reports/9900417.pdf. Accessed March 10, 2006.
48. Mehin R, Yuan X, Haydon C, et al. Retroacetabular osteolysis: When to operate? Clin Orthop Relat Res 2004;428:247-55.
49. Ritter MA, Albohm MJ. Overview: maintaining outcomes for total hip arthroplasty. The past, present, and future. Clin Orthop Relat Res 1997;344:81-7.
50. Howe JG. Critical pathways in total hip arthroplasty. In: Callaghan JJ, Rosenberg AG, Rubash HE, editors. The adult hip. Philadelphia: Lippincott-Raven; 1998.
51. British Orthopaedic Association. Total hip replacement: a guide to best practice. London: British Orthopaedic Association; 1999.
52. Veysi VT, Jones S, Stone MH, Limb D. Out-patient follow-up after total hip replacement in one health region. J R Coll Surg Edinb 1998;43:95-6.
53. Teeny SM, York SC, Mesko JW, Rea RE. Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American Association of Hip and Knee Surgeons' member survey. J Arthroplasty 2003;18:954-62.
54. Katz JN, Losina E, Barrett J, et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am 2001;83:1622-9.
55. Katz JN, Phillips CB, Baron JA, et al. Association of hospital and surgeon volume of total hip replacement with functional status and satisfaction three years following surgery. Arthritis Rheum 2003;48:560-8.
56. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
57. US National Institutes of Health. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med 1985;103:147-51.
58. Mancuso CA, Charlson ME. Does recollection error threaten the validity of cross-sectional studies of effectiveness? Med Care 1995;33 Suppl:AS77-88.
59. Mahomed NN, Arndt DC, McGrory BJ, Harris WH. The Harris hip score: comparison of patient self-report with surgeon assessment. J Arthroplasty 2001;16:575-80.
60. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
61. American Psychiatric Association. Diagnostic and statistical manual, text revision. 4th ed. Arlington, VA: American Psychiatric Association; 2000.
62. Losina E, Barrett J, Baron JA, Levy M, Phillips CB, Katz JN. Utilization of low-volume hospitals for total hip replacement. Arthritis Rheum 2004;51:836-42.
63. Snedker K, Glynn P, Wang C. Ordered/ordinal logistic regression with SAS and STATA; 2002. Available from: http://staff. washington.edu/~glynn/olr.pdf. Accessed March 10, 2006.
64. Mahomed NN, Barrett JA, Katz JN, et al. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am 2003;85:27-32.
65. Fortin PR, Clarke AE, Joseph L, et al. Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum 1999;42:1722-8.
66. Lingard EA, Wright EA, Sledge CB. Pitfalls of using patient recall to derive preoperative status in outcome studies of total knee arthroplasty. J Bone Joint Surg Am 2001;83:1149-56.
67. Wildner M. Lost to follow-up. J Bone Joint Surg Br 1995;77:657.
68. Murray DW, Britton AR, Bulstrode CJ. Loss to follow-up matters. J Bone Joint Surg Br 1997;79:254-7.
69. Kim J, Lonner JH, Nelson CL, Lotke PA. Response bias: effect on outcomes evaluation by mail surveys after total knee arthroplasty. J Bone Joint Surg Am 2004;86:15-21.
70. King PJ, Malin AS, Scott RD, Thornhill TS. The fate of patients not returning for follow-up five years after total knee arthroplasty. J Bone Joint Surg Am 2004;86:897-901.